Viral encephalitis masquerading as a fulminant anticholinergic toxidrome

Journal of Toxicology - Clinical Toxicology

Volumn 35, Issue 6, 1997, Pages 627-633

  Perrone, Jeanmarie ^a,c   Chu, John ^b   Stecker, Mark M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; LORAZEPAM; PARACETAMOL; PHENYTOIN; PHYSOSTIGMINE;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CASE REPORT; CHOLINERGIC TRANSMISSION; ELECTROENCEPHALOGRAM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; SYMPTOM; THERAPY; VIRUS ENCEPHALITIS;

EID: 0030727382     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659709001244     Document Type: Article

References (12)

1. Aquilonius SM, Hedstrand U. The use of physostigmine as an antidote in tricyclic antidepressant intoxication. Acta Anaesthesiol Scand 1978;22:40-45.
2. Kleinwachter Beobachtungen uber die Wirkung des Calabar Extracts gegen Atropinvergiftung. Berl Klin Wschr 1864;11:369.
3. Burks JS, Walker JE, Rumack BH, Ott JE. Tricyclic antidepressant poisoning. Reversal of coma, choreoathetosis, and myoclonus by physostigmine. JAMA 1974:230:1405-1407.
4. Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med 1980;9:588-590.
5. Newton RW. Physostigmine salicylate in the treatment of tricyclic antidepressant overdosage. JAMA 1975;231:941-943.
6. Vance MA, Ross SM, Millington WR, Blumberg JB. Potentiation of tricyclic antidepressant toxicity by physostigmine in mice. Clin Toxicol 1977;11: 413-421.
7. Baum PA, Barkovich AJ, Koch TK, Berg BO. Deep gray matter involvement in children with acute disseminated encephalomyelitis. Am J Neuroradiol 1994;15:1275-1283.
8. Hart MN, Earle KM. Haemorrhagic and perivenous encephalitis: A clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975;38: 585-591.
9. Loizzo A, Longo V. EEG effects of cholinergic and anticholinergic drugs. In: The Handbook of Electroencephalography and Clinical Neurophysiology. Remond A., ed., 1977;7C:7-22.
10. Santucci V, Glatt A, Demieville H, Olpe HR. Quantification of slow-wave EEG induced by atropine: Effects of physostigmine, amphetamine and haloperidol. Eur J Pharmacol 1981;73:113-122.
11. Miura Y, Ito T, Kadokawa T. Acute EEG changes in rats by brainstem ischemia and its dopaminergic involvement. Jpn J Pharmacol 1985;39:443-451.
12. Gustafson L, Edvinsson L, Dahlgren N, et al. Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. Psychopharmacology Berl 1987;93:31-35.